Spulenanordnung und System zur transkraniellen Magnetstimulation

ROBMIT – ROBotic MIrrored Therapy after stroke

Transkranielle Hirnstimulation zur Untersuchung von Gedächtnisverarbeitung und synaptischer Plastizität während des Schlafes

BOSS-STROKE – Hirnzustandsabhängige, transkranielle Magnetstimulation zur motorischen Rehabilitation der oberen Extremität in frühen Schlaganfallstadien

ClinBrAIn: Künstliche Intelligenz für Klinische Hirnforschung

SMARTCOIL – Personalisierte therapeutische Hirnstimulation

Forschungsstipendium – Forschungsstipendien - Promotion in Deutschland, 2018/19

64. Jahrestagung der Deutschen Gesellschaft für Klinische Neurophysiologie und Funktionelle Bildgebung Baden-Baden 26.-28.03.2020

CERETEP – Electroencephalographical signatures in cerebral cortex evoked by cerebellar transcranial magnetic stimulation

Annexai

Apices

Axiomatic - BMS – A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Response-Adaptive Dose-Ranging Study of BMS-986177, an Oral Factor XIa Inhibitor, for the Prevention of New Ischemic Stroke or New Covert Brain Infarction in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

Closed-loop TMS triggered by real-time cortical excitability states for neural rehabilitation of patients with disorders of consciousness

ConnectToBrain – Connecting to the Networks of the Human Brain

Prestige AF

Registry of Idarucizumab for Patients with IntraCranial Hemmorrhage (RIC-ICH)

REHALITY – Verbundprojekt: Closed-loop Softwaresystem zur Neurorehabilitation nach Schlaganfall durch personalisiertes EEG/EMG-Hirnzustand-gesteuertes Virtual Reality-Therapieparadigma

SANO – Strukturierte ambulante Nachsorge nach Schlaganfall (SANO)

STREAM

ENSEMBLE – AN OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATETHE EFFECTIVENESS AND SAFETY OFOCRELIZUMAB IN PATIENTS WITH EARLY STAGERELAPSING REMITTING MULTIPLE SCLEROSIS

Kooperationsvertrag zwischen UKT und m&i Klinikgruppe Enzensberg

The sensorimotor µ-rhythm as cholinergically controlled pulsed inhibition

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

DS1040-A-U103 – DS1040b in subjects with acute ischemic stroke

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. A randomised, open, phase III, clinical trial with blinded outcome assessment

ATTICUS – Apixaban for treatment of embolic stroke of undetermined source

Bai, Yang